← back to search

Rasmus Wentzer Licht

Aalborg University Hospital · DK
Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Bipolar Disorder and Treatment, Schizophrenia research and treatment, Treatment of Major Depression, and Electroconvulsive Therapy Studies.
h-index
45
citations
9,290
works
272
NIH funding
primary concept
Medicine
email

Recent publications

The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
2025cited by 24position: contributordoi
Lithium versus cariprazine in the acute phase treatment for depressive episodes in patients with bipolar disorder: a protocol for a pragmatic open, randomised multicentre study - the 9th trial of the Danish University Antidepressant Group, DUAG-9.
2025cited by 0position: contributordoi
Association between a large change between the minimum and maximum monthly values of solar insolation and a history of suicide attempts in bipolar I disorder.
2024cited by 2position: contributordoi
Invited commentary to Professor Belmaker's letter on lithium treatment for bipolar disorder.
2024cited by 1position: contributordoi
Correspondence on "An algorithm for pharmacological treatment of mania during hospitalisation".
2024cited by 0position: contributordoi
A comment and correction.
2024cited by 0position: contributordoi
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
2023cited by 109position: contributordoi
The true effect of lithium is hard to determine.
2023cited by 3position: contributordoi
Characteristics prior to and at time of diagnosis in pediatric bipolar disorder.
2023cited by 0position: contributordoi
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder.
2023cited by 0position: contributordoi
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
New England Journal of Medicine 2022cited by 1,042position: middledoi
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
2022cited by 754position: contributordoi
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs
European Neuropsychopharmacology 2022cited by 15position: contributordoi
Association between polarity of first episode and solar insolation in bipolar I disorder.
2022cited by 12position: contributordoi
Lithium induced hypercalcemia: an expert opinion and management algorithm.
2022cited by 10position: contributordoi
Validation of the Affect Integration Inventory in a sample of patients with personality disorders: A cross-sectional study.
2022cited by 5position: contributordoi
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review.
2022cited by 4position: contributordoi
[Bipolar depression, a challenge diagnostic and treatmentwise].
2022cited by 1position: contributor
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network.
2021cited by 34position: contributordoi
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder
International Journal of Bipolar Disorders 2021cited by 27position: middledoi
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder.
2021cited by 17position: contributordoi
Emotional dysfunction in avoidant personality disorder and borderline personality disorder: A cross-sectional comparative study.
2021cited by 4position: contributordoi
The Relationship between Affect Integration and Psychopathology in Patients with Personality Disorder: A Cross-Sectional Study.
2021cited by 4position: contributordoi
Lithium as a first-step option for acute phase pharmacotherapy of bipolar depression.
2021cited by 1position: contributordoi
Occurrence and accuracy of a register-based diagnosis of pediatric bipolar disorder: A nationwide cohort study.
2021cited by 0position: contributordoi
A skewed perspective - A reply to Kovvuru et al.
2021cited by 0position: contributordoi
Corrigendum to "Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121-136]".
2021cited by 0position: contributordoi
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action.
2020cited by 15position: contributordoi
Transcranial pulsed electromagnetic fields for treatment-resistant depression: A multicenter 8-week single-arm cohort study.
2020cited by 9position: contributordoi
Excess mortality in subjects with severe mental illness: A matter of serious concern.
2020cited by 5position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Mirko Manchia · Magna Graecia University10 papers (2019–2024) · 8 papers (2019–2025) · 6 papers (2021–2025)Tomas Hajek · Weatherford College6 papers (2019–2022)F. Kapczinski · Fundação de Amparo à Pesquisa do Estado de São Paulo5 papers (2021–2024)Ralph Kupka · Bohn Stafleu van Loghum (Netherlands)5 papers (2019–2022)Carlos Lopez-Jaramillo · Católica del Norte Fundación Universitaria5 papers (2021–2024)E. Isometsä · Helsinki Institute of Physics4 papers (2021–2024)Andrea Pfennig · University of Oslo4 papers (2021–2024)Konstantinos Ν. Fountoulakis · Academic College of Tel Aviv-Yafo4 papers (2019–2023)Willem A. Nolen · University of Groningen3 papers (2019–2021)Raj Ramesar · South African Medical Research Council3 papers (2021–2023)S. Strejilevich · Instituto de Química del Noroeste Argentino3 papers (2021–2022)Ana M González‐Pinto · Complejo Hospitalario Universitario de Santiago3 papers (2021–2021)John R. Geddes · Leeds Teaching Hospitals NHS Trust3 papers (2020–2021)Ingrid Melle · Weatherford College3 papers (2021–2023)Robert A Schoevers · Erasmus University Rotterdam3 papers (2022–2025)Allan H. Young · King's College Hospital3 papers (2023–2025)Andreas Bechdolf · University Hospital Cologne3 papers (2020–2022)David J. Hellerstein · New York Psychoanalytic Society and Institute3 papers (2022–2025)